These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7231094)

  • 1. Hormone markers for cancer.
    Weintraub BD
    Med Times; 1981 May; 109(5):37-9. PubMed ID: 7231094
    [No Abstract]   [Full Text] [Related]  

  • 2. Useful blood tests in the diagnosis and management of cancer: a review. Part II.
    Hartman HA; Foley JF
    Nebr Med J; 1977 May; 62(5):151-4. PubMed ID: 854126
    [No Abstract]   [Full Text] [Related]  

  • 3. [Reliability and standardization of hormone determinations (author's transl)].
    Breuer H; Röhle G
    Schweiz Rundsch Med Prax; 1981 Jan; 70(4):101-9. PubMed ID: 7208417
    [No Abstract]   [Full Text] [Related]  

  • 4. [The value of the parathyrin-related protein (PTH-RP) in the diagnosis of cancer-associated hypercalcemia].
    Sagarra E; Villabona C; Bonnin R; Moliner R; Merino FJ; Sahún M; Soler J
    Med Clin (Barc); 1995 Oct; 105(12):450-4. PubMed ID: 7490935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: The value of hormone measurements in tumour management.
    Bagshawe KD
    Br J Cancer; 1974 Aug; 30(2):187. PubMed ID: 4419492
    [No Abstract]   [Full Text] [Related]  

  • 6. Levels of circulating peptide and steroid hormones in men with lung cancer.
    Bhatavdekar JM; Patel DD; Chikhlikar PR; Mehta RH; Vora HH; Karelia NH; Ghosh N; Shah NG; Suthar TP; Neema JP
    Neoplasma; 1994; 41(2):101-3. PubMed ID: 8208311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating hormone levels in breast cancer patients. correlation with serum tumor markers and the clinical and biological features of the tumors.
    Hernández L; Nuñez-Villarl MJ; Martínez-Arribas F; Pollán M; Schneider J
    Anticancer Res; 2005; 25(1B):451-4. PubMed ID: 15816610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of transcranial electrostimulation for pain relief in cancer patients].
    Evtiukhin AI; Dunaevskiĭ IV; Shabut AM; Aleksandrov VA
    Vopr Onkol; 1998; 44(2):229-33. PubMed ID: 9615834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of tumour markers in cancer diagnosis and treatment.
    Higgins C
    Nurs Times; 1996 Apr 17-23; 92(16):36-7. PubMed ID: 8710591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anomalous effects of hormone fragments on the measurement of parathyroid hormone by radioimmunoassay.
    Mbuyi-Kalala A; Ehrenstein G
    Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):87-99. PubMed ID: 8740240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of gastrointestinal hormone release in patients with lung cancer.
    Yamashita Y; Miyahara E; Shimizu K; Toge T; Adrian TE
    In Vivo; 2003; 17(2):193-5. PubMed ID: 12792985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endocrine profiles in men with localized and locally advanced prostate cancer treated with radical prostatectomy.
    Heracek J; Urban M; Sachova J; Kuncova J; Eis V; Mandys V; Hampl R; Starka L
    Neuro Endocrinol Lett; 2007 Feb; 28(1):45-51. PubMed ID: 17277727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms linking physical activity with cancer.
    McTiernan A
    Nat Rev Cancer; 2008 Mar; 8(3):205-11. PubMed ID: 18235448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of fetal hormone levels with stem cell potential: evidence for early life roots of human cancer.
    Baik I; Devito WJ; Ballen K; Becker PS; Okulicz W; Liu Q; Delpapa E; Lagiou P; Sturgeon S; Trichopoulos D; Quesenberry PJ; Hsieh CC
    Cancer Res; 2005 Jan; 65(1):358-63. PubMed ID: 15665314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers for the early detection of cancer: an inflammatory concept.
    Roy HK; Khandekar JD
    Arch Intern Med; 2007 Sep; 167(17):1822-4. PubMed ID: 17893302
    [No Abstract]   [Full Text] [Related]  

  • 16. Tea, hormone-related cancers and endogenous hormone levels.
    Wu AH; Yu MC
    Mol Nutr Food Res; 2006 Feb; 50(2):160-9. PubMed ID: 16470648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why are there discrepancies between clinical symptoms and the hormone level in blood?
    Simionescu L
    Endocrinologie; 1981; 19(4):265-8. PubMed ID: 7323652
    [No Abstract]   [Full Text] [Related]  

  • 18. Assay reproducibility of hormone measurements in postmenopausal women.
    Falk RT; Dorgan JF; Kahle L; Potischman N; Longcope C
    Cancer Epidemiol Biomarkers Prev; 1997 Jun; 6(6):429-32. PubMed ID: 9184776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Several hormonal indices during hemofiltration in patients with acute kidney failure].
    Timokhov VS; Kazakov IV; Semenov VN; Bobkov AI
    Ter Arkh; 2001; 73(2):50-4. PubMed ID: 11338856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.